Guidance: MenACWY programme: information for healthcare professionals
Safety Classified by Officially
The meningococcal ACWY (MenACWY) vaccine was introduced in response to an increase in cases of invasive meningococcal disease capsular group W (MenW) disease.
The vaccine has successfully provided direct protection to the vaccinated cohort and, by reducing carriage of MenW and MenC, has also provided indirect protection to unvaccinated children and adults. From 1 July 2025 MenC vaccine will no longer be offered to infants and these MenACWY resources have been updated to reflect this change. Maintaining high uptake of MenACWY vaccine amongst teenagers is important so that they, and unvaccinated children and adults continue to be protected.
This information for healthcare professionals about the MenACWY programme includes details on:
This is an extract. The publication continues at the source.
Contains public sector information licensed under the Open Government Licence v3.0. Licence
Read the original at the source: https://www.gov.uk/government/publications/menacwy-programme-information-for-healthcare-professionals
Officially imported this from UK Health Security Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- UK Health Security Agency — imported from official source
- Official source
- https://www.gov.uk/government/organisations/uk-health-security-agency.atom ATOM
- Imported
- November 10, 2026 16:01
- Versions
- 1 recorded
- Identity
-
https://www.gov.uk/government/publications/menacwy-programme-information-for-healthcare...